Compare Wegovy vs Mounjaro: Stock Status & Clinical Facts
Which Is Best Wegovy or Mounjaro for UK Patients: Current Availability
The question of which is best between Wegovy or Mounjaro often comes down to individual clinical factors and, crucially, reliable availability. After months of supply challenges across the UK, both treatments are now consistently in stock at EverydayMeds with all doses available for immediate dispatch. Wegovy's complete dose escalation pathway (0.25mg through 2.4mg) is available alongside Mounjaro's full range, ensuring patients can start their weight management journey without delays. Our direct partnerships with Novo Nordisk and Eli Lilly provide consistent supply chains that have eliminated the waitlists that previously frustrated patients.
When considering which is best Wegovy or Mounjaro, availability confidence plays a crucial role in treatment adherence. Patients need assurance that their chosen medication will remain accessible throughout their weight management journey. EverydayMeds maintains strategic stock levels of both treatments, with automated reordering systems that prevent supply gaps. This reliability means prescribers can focus on clinical suitability rather than availability constraints. Both treatments require consistent weekly dosing, making uninterrupted supply essential for optimal outcomes alongside a reduced-calorie diet and increased physical activity.
Wegovy vs Mounjaro Pricing: Which Is Best Value in the UK
Determining which is best between Wegovy or Mounjaro requires understanding the complete cost structure for each treatment pathway. Wegovy's dose escalation begins at £79.99 for the 0.25mg starter dose (after applying discount code FIRST40), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Intro Trio bundle provides the first three doses (0.25mg, 0.5mg, and 1mg) for £299.99, covering the initial 12-week titration period. Returning customers benefit from the DOSE25 discount code applied at checkout, ensuring ongoing affordability throughout their treatment journey.
The question of which is best Wegovy or Mounjaro from a value perspective extends beyond initial pricing to consider storage convenience and dose flexibility. Wegovy's advantage lies in its extended room temperature storage capability—6 weeks compared to Mounjaro's 21 days—reducing travel restrictions and storage anxiety. This practical benefit can influence long-term treatment costs by minimising medication wastage due to temperature excursions. Both prescription-only medicines require ongoing clinical monitoring, but Wegovy's established NHS pathway through NICE TA875 may offer future cost advantages for eligible patients transitioning from private to specialist NHS weight management services.
Clinical Evidence: Which Is Best Wegovy or Mounjaro Based on Research
When evaluating which is best Wegovy or Mounjaro, clinical trial data provides essential context, though direct head-to-head comparisons remain limited. Wegovy's efficacy is demonstrated through the comprehensive STEP trial programme, with STEP 1 showing approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, adding significant clinical value beyond weight management. These results reflect treatment alongside intensive lifestyle interventions, not medication alone.
Mounjaro's clinical profile stems from its unique dual GIP and GLP-1 receptor agonist mechanism, distinguishing it from Wegovy's single GLP-1 approach when considering which is best. However, comparing trial weight loss percentages directly between treatments isn't clinically meaningful due to different study designs, patient populations, and primary endpoints. Both medications demonstrate significant efficacy when prescribed as part of comprehensive weight management programmes including dietary modifications and exercise regimens. The choice of which is best Wegovy or Mounjaro should ultimately depend on individual patient characteristics, tolerance profiles, and prescriber clinical judgment rather than headline trial percentages.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a naturally occurring hormone released after eating. This mechanism reduces appetite by acting on appetite centres in the brain, specifically the hypothalamus, leading to decreased food intake and enhanced feelings of fullness after smaller meals. The medication also slows gastric emptying, prolonging satiety signals and reducing the frequency of hunger between meals. Unlike rapid-acting appetite suppressants, Wegovy's effects build gradually during the dose escalation phase, allowing patients to adjust to new eating patterns sustainably. Weekly subcutaneous injection via the FlexTouch pen device ensures consistent medication levels, supporting steady appetite regulation throughout the treatment period. This mechanism requires combination with behavioural changes—including a reduced-calorie diet and increased physical activity—to achieve optimal weight management outcomes.
Ordering Process: Getting Wegovy or Mounjaro in Stock UK
The process for accessing either medication when considering which is best Wegovy or Mounjaro begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our prescribers review each application within 3 working days (or 24 hours with express service), ensuring clinical appropriateness before approving either treatment. Once approved, medications dispatch via next-day cold-chain delivery, maintaining the 2-8°C storage requirements essential for maintaining medication stability and efficacy. The GPhC-registered pharmacy #9012878 status ensures all dispensing meets UK regulatory standards, with full traceability and patient safety protocols. Ongoing prescriber support remains available throughout treatment, with dose adjustment guidance and side effect management as needed. This streamlined process eliminates the traditional GP waiting times while maintaining clinical oversight essential for prescription-only medicines.
Storage and Practical Considerations: Wegovy vs Mounjaro Convenience
Storage requirements significantly impact the practical question of which is best Wegovy or Mounjaro for individual lifestyles. Wegovy offers a distinct advantage with 6 weeks of room temperature stability below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. This extended stability benefits frequent travellers, students, or professionals with unpredictable schedules who may struggle with consistent refrigerated storage. Both medications require initial refrigerated storage at 2-8°C before first use, but Wegovy's flexibility reduces anxiety about temperature excursions during travel or power outages. The FlexTouch pen design provides intuitive dose administration, with clear dose escalation markings and safety features preventing accidental overdosing. Weekly injection scheduling allows flexibility in timing—patients can adjust injection days to suit their routine, maintaining 7-day intervals between doses throughout the escalation and maintenance phases.
Which Is Best Wegovy or Mounjaro: Mechanism Differences Matter
The fundamental question of which is best Wegovy or Mounjaro often centres on their distinct mechanisms of action and how these translate to individual patient responses. Wegovy's single GLP-1 receptor agonism provides targeted appetite suppression through well-established pathways, offering predictable effects based on extensive clinical experience. Mounjaro's dual GIP and GLP-1 receptor agonism introduces additional complexity through its novel mechanism, potentially offering different tolerance profiles or efficacy patterns in specific patient populations. These mechanistic differences may influence side effect profiles, dose titration requirements, and long-term adherence rates.
Prescriber preference often guides the decision of which is best Wegovy or Mounjaro based on patient-specific factors including concurrent medications, comorbidities, and previous treatment responses. Wegovy's established position in UK clinical guidelines through NICE TA875 provides clear prescribing pathways and potential future NHS access routes for eligible patients. Both treatments require identical lifestyle interventions and monitoring protocols, ensuring that the choice between mechanisms doesn't compromise the comprehensive care essential for successful weight management. EverydayMeds prescribers evaluate these factors during clinical assessment, ensuring the selected treatment aligns with individual patient needs and circumstances.
Order Your Chosen Treatment: Both Wegovy and Mounjaro Available Now
Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which is right for you based on individual clinical factors and preferences. New customers can apply discount code FIRST40 at checkout, while returning customers use code DOSE25 to access our competitive pricing structure. The complete Wegovy dose range from £79.99 (0.25mg starter) through £209.99 (2.4mg maintenance) ensures affordable access throughout your treatment journey. Bundle options like our Intro Trio (£299.99) provide cost-effective dose progression while guaranteeing supply continuity. Our clinical team remains available for ongoing support, dose adjustments, and guidance as your treatment progresses, ensuring both safety and efficacy throughout your weight management journey. Start your assessment today at https://everydaymeds.co.uk/collections/wegovy to access both treatments with expert clinical oversight and Reliable UK stock availability.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
